Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking approach to diabetes management. These innovative therapies function by mimicking the natural actions of GLP-1, a hormone secreted by the gut https://push2bookmark.com/story20948811/reta-glucagon-like-peptide-1-receptor-agonists